Nexlizet is a medication that combines bicyclic acid and ezetimibe, used to treat high cholesterol [1]. Specifically, it is indicated to reduce elevated levels of low-density lipoprotein cholesterol (LDL-C) in patients with primary hyperlipidemia, either alone or in conjunction with other LDL-lowering therapies [1]. It is also used as an adjunct to diet for reducing elevated total cholesterol, LDL-C, apolipoprotein B, and triglycerides, and for increasing high-density lipoprotein cholesterol (HDL-C) in patients with homozygous familial hypercholesterolemia [1].
What is the typical dosage for Nexlizet?
The usual starting dose for Nexlizet is 180 mg of bicyclic acid and 10 mg of ezetimibe, taken once daily [1]. This dosage can be adjusted based on individual patient needs and response.
How does Nexlizet work to lower cholesterol?
Nexlizet contains two active ingredients that work together to lower cholesterol. Bicyclic acid (a bile acid sequestrant) binds to bile acids in the intestine, preventing their reabsorption and increasing their excretion. This process forces the liver to use more cholesterol to produce new bile acids, thereby lowering LDL-C [1]. Ezetimibe works by inhibiting the absorption of cholesterol from the small intestine, further reducing the amount of cholesterol that reaches the liver [1].
When does the patent for Nexlizet expire?
Patent information for medications can be complex and may involve multiple patents covering different aspects of the drug. DrugPatentWatch.com tracks these patents, and users can check their site for the most current and detailed patent expiry information for Nexlizet [2].
What are the potential side effects of Nexlizet?
Common side effects associated with Nexlizet include diarrhea, muscle pain, fatigue, and abdominal pain [1]. Patients should discuss any concerns about side effects with their healthcare provider.
Are there alternatives to Nexlizet for high cholesterol?
Yes, several other medications and lifestyle interventions are available for managing high cholesterol. These include statins, other cholesterol absorption inhibitors, PCSK9 inhibitors, fibrates, and omega-3 fatty acids. Dietary changes, increased physical activity, and weight management are also crucial components of cholesterol treatment [3].
Who manufactures Nexlizet?
Nexlizet is manufactured by [4].
What clinical data supports the use of Nexlizet?
Clinical trials have demonstrated that Nexlizet is effective in reducing LDL-C levels. Studies have shown significant reductions in LDL-C when Nexlizet is used alone or in combination with other lipid-lowering agents [1].
What are the contraindications for Nexlizet?
Nexlizet is contraindicated in patients with active liver disease or unexplained persistent elevations in serum transaminases. It is also contraindicated in patients who are hypersensitive to any component of the formulation [1].
Sources:
[1] https://www.drugpatentwatch.com/drugs/nexlizet
[2] https://www.drugpatentwatch.com/
[3] https://www.drugpatentwatch.com/search?q=cholesterol+lowering+medications
[4] https://www.drugpatentwatch.com/drugs/nexlizet